These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 2072038
1. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects. Barrett PH, Baker N, Nestel PJ. J Lipid Res; 1991 May; 32(5):743-62. PubMed ID: 2072038 [Abstract] [Full Text] [Related]
2. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. Packard CJ, Gaw A, Demant T, Shepherd J. J Lipid Res; 1995 Jan; 36(1):172-87. PubMed ID: 7706942 [Abstract] [Full Text] [Related]
7. Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes. Vergès B, Florentin E, Baillot-Rudoni S, Monier S, Petit JM, Rageot D, Gambert P, Duvillard L. Diabetologia; 2008 Aug; 51(8):1382-90. PubMed ID: 18535816 [Abstract] [Full Text] [Related]
8. Studies on the metabolism of apolipoprotein B in hypertriglyceridemic subjects using simultaneous administration of tritiated leucine and radioiodinated very low density lipoprotein. Beltz WF, Kesäniemi YA, Miller NH, Fisher WR, Grundy SM, Zech LA. J Lipid Res; 1990 Mar; 31(3):361-74. PubMed ID: 2341804 [Abstract] [Full Text] [Related]
9. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. Packard CJ, Munro A, Lorimer AR, Gotto AM, Shepherd J. J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922 [Abstract] [Full Text] [Related]
10. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects. Björnson E, Packard CJ, Adiels M, Andersson L, Matikainen N, Söderlund S, Kahri J, Hakkarainen A, Lundbom N, Lundbom J, Sihlbom C, Thorsell A, Zhou H, Taskinen MR, Borén J. J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520 [Abstract] [Full Text] [Related]
11. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes. Taskinen MR, Björnson E, Kahri J, Söderlund S, Matikainen N, Porthan K, Ainola M, Hakkarainen A, Lundbom N, Fermanelli V, Fuchs J, Thorsell A, Kronenberg F, Andersson L, Adiels M, Packard CJ, Borén J. Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392 [Abstract] [Full Text] [Related]
12. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. Campos E, Nakajima K, Tanaka A, Havel RJ. J Lipid Res; 1992 Mar; 33(3):369-80. PubMed ID: 1569386 [Abstract] [Full Text] [Related]
13. In vivo studies of VLDL metabolism and LDL heterogeneity. Demant T, Packard C. Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058 [Abstract] [Full Text] [Related]
14. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy. Taskinen MR, Matikainen N, Björnson E, Söderlund S, Inkeri J, Hakkarainen A, Parviainen H, Sihlbom C, Thorsell A, Andersson L, Adiels M, Packard CJ, Borén J. Diabetologia; 2023 Dec; 66(12):2307-2319. PubMed ID: 37775612 [Abstract] [Full Text] [Related]
15. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, Bedynek A, Shepherd J, Seidel D. J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415 [Abstract] [Full Text] [Related]
16. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. Campos H, Perlov D, Khoo C, Sacks FM. J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625 [Abstract] [Full Text] [Related]
17. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. Zulewski H, Ninnis R, Miserez AR, Baumstark MW, Keller U. J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998 [Abstract] [Full Text] [Related]
18. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. Sattar N, Greer IA, Louden J, Lindsay G, McConnell M, Shepherd J, Packard CJ. J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322 [Abstract] [Full Text] [Related]
19. Heterogeneity of very-low-density lipoprotein metabolism in hyperlipidemic subjects. Nestel P, Billington T, Tada N, Nugent P, Fidge N. Metabolism; 1983 Aug; 32(8):810-7. PubMed ID: 6865779 [Abstract] [Full Text] [Related]
20. Effects of simvastatin on apoB metabolism and LDL subfraction distribution. Gaw A, Packard CJ, Murray EF, Lindsay GM, Griffin BA, Caslake MJ, Vallance BD, Lorimer AR, Shepherd J. Arterioscler Thromb; 1993 Feb; 13(2):170-89. PubMed ID: 8427854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]